1Neurocognitive research center & department of physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2Neurogenic inflammation research center & department of physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3Department of physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Objective: The incidence and prevalence of kidney stone is increasing worldwide. After the first recurrence the risk of subsequent relapses is higher and the time period between relapses is shortened. Urinary stones can be severely painful and make a huge economic burden. The stone disease may increase the vulnerability of patients to other diseases such as renal failure. Medicinal herbs are rich sources of antioxidants which are increasingly consumed globally for their safety, efficacy and low price. Nigella sativa is a spice plant that is widely used for prevention and treatment of many ailments in Muslim countries and worldwide. This review aims at investigation of the effects of Nigella sativa on renal injury and stone formation. Materials and Method: The scientific resources including PubMed, Scopus, and Google scholar were searched using key words such as: nephrolithiasis, urolithiasis, kidney/renal stone, renal injury, renal failure, urinary retention and black seed, black cumin, Nigella sativa and thymoquinone. Results: N. sativa and its main component, thymoquinone showed positive effects in prevention or curing kidney stones and renal failure through various mechanism such as antioxidative, anti-inflammatory, anti-eicosanoid and immunomodulatory effects. The putative candidate in many cases has been claimed to be thymoquinone but it seems that at least in part, particularly in kidney stones, the herbal melanin plays a role which requires further investigation to prove. Conclusion: N. sativa and its components are beneficial in prevention and curing of renal diseases including nephrolithiasis and renal damages.
Ahmed OG, El-Mottaleb NA, 2013. Renal function and arterial blood pressure alterations after exposure to acetaminophen with a potential role of Nigella sativa oil in adult male rats. J Physiol Biochem, 69: 1–13.
Ali B H, Blunden G. 2003. Pharmacological and Toxicological Properties of Nigella sativa. Phytother Res, 305: 299–305.
Alok S, Jain SK, Verma A, Kumar M, Sabharwal M. 2013. Pathophysiology of kidney , gallbladder and urinary stones treatment with herbal and allopathic medicine : A review. Asian Pac J Trop Dis, 3: 496–504. Anders HJ, Banas B, Schlondorff D. 2004. Signaling Danger : Toll-Like Receptors and their Potential Roles in Kidney Disease. J Am Soc Nephrol, 15: 854–867.
Awad AS, Kamel R., Sherief ME. 2011. Effect of thymoquinone on hepatorenal dysfunction and alteration of CYP3A1 and spermidine / spermine N-1-acetyl-transferase gene expression induced by renal ischaemia – reperfusion in rats. J Pharm Pharmacol, 63: 1037–1042.
Bayrak O, Bavbek N, Karatas OF, Bayrak R., Catal F, Cimentepe E, Akbas A, et al. 2008. Nigella sativa protects against ischaemia / reperfusion injury in rat kidneys. Nephrol Dial Transplant, 23: 2206–2212.
Chou Y, Li C, Hsu H, Chang W, Liu C. 2011. Renal function in patients with urinary stones of varying compositions. KJMS, 27:264–267.
Coe FL, Evan A, Worcester E. 2005. Kidney stone disease. J Clin Invest, 115:2598–2608.
Deepika A, Minu S, Surinder KS. 2013. The role of natural antioxidants as potential therapeutic agents in nephrolithiasis. Asian J Pharm Clin Res, 6: 1–6.
El-obeid A, Westermark B, Hassib A, Ponte F. 2006. Effect of herbal melanin on IL-8: A possible role of Toll-like receptor 4 (TLR4). Biochem Bioph Res Co, 344:1200–1206.
Fararh K M, Atoji Y, Shimizu Y, Takewaki T. 2002. Isulinotropic properties of Nigella sativa oil in Streptozotocin plus Nicotinamide diabetic hamster. Res Vet Sci, 73: 279–282.
Grases F, Costa-bauza A, Prieto R M. 2006. Renal lithiasis and nutrition. Nut J, 5: 1–7.
Hadjzadeh M R, Khoei A, Hadjzadeh Z. 2007. Ethanolic Extract of Nigella Sativa L Seeds on Ethylene Glycol-Induced Kidney Calculi in Rats. Urol J, 4: 86–90.
Hadjzadeh MR, Mohammadian N, Rahmani Z. 2008. Effect of Thymoquinone on Ethylene Glycol-Induced Kidney Calculi in Rats. Urol J, 5: 149–155.
Hadjzadeh MR, Khajavi-rad A, Rajaei Z, Tehranipour M, Monavar N. 2011. The preventive effect of N-butanol fraction of Nigella sativa on ethylene glycol-induced kidney calculi in rats. Pharmacogn Mag, 7: 338–343.
Hamed MA, Ali SA. 2013. Effects of black seed oil on resolution of hepato-renal toxicity induced by bromobenzene in rats. Eur Rev Med Pharmacol Sci, 17: 569–581.
Havakhah S, Sadeghnia HR., Hajzadeh MR, Mohammadian N, Shafiee S, Hosseinzadeh H, Mohareri N, et al. 2014. Effect of Nigella sativa on ischemia-reperfusion induced rat kidney damage.
IJBMS, 17: 986–992.
Heilberg IP 2000. Nephrology Dialysis Transplantation Update on dietary recommendations and medical treatment of renal stone disease. Nephrol Dial Transplant, 15: 117–123.
Irani D, Eshratkhah R, Amin-sharifi A. 2005. Efficacy of Extracorporeal shock wave lithotripsy Monotherapy in Complex Urolithiasis in the Era of Advanced Endourologic Procedures. Urol J, 2: 13–19.
Jayakar B. 2002. Anti-ulcer effect of Nigella sativa Linn . against gastric ulcers in rats. Curr Sci India, 82: 177–179.
Jonassen JA, Kohjimoto Æ Y, Scheid C R, Schmidt Æ M. 2005. Oxalate toxicity in renal cells. Urol Res., 33: 329–339.
Kanter M, Coskun O, Budancamanak M. 2005. Hepatoprotective effects of Nigella sativa L and Urtica dioica L on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbon tetrachloride-treated rats. World J Gastroenterol, 11: 6684–8.
Karaolanis G, Lionaki S, Moris D, Palla V, Vernadakis S. 2014. Secondary hyperoxaluria : a risk factor for kidney stone formation and renal failure in native kidneys and renal grafts. Transplant Rev, 28: 182–187.
Khajavi rad A, Hadjzadeh MR, Monavvar N. 2008. Preventive effects of ethyl acetate fractions from aqueous and ethanolic extract of Nigella sativa L. seeds on calcium oxalate kidney stones in Wistar rats. Koomesh, 9: 123–132.
Khattab MM, Nagi MN. 2007. Thymoquinone Supplementation attenuates Hypertension and Renal Damage in Nitric Oxide deficient Hypertensive Rats. Phytother Res, 414: 410–414.
Liu X, Zheng J, Zhou H. 2011. TLRs as pharmacological targets for plant-derived compounds in infectious and inflammatory diseases. Int immunopharmacol, 11: 1451–1456.
Mckenzie G, Hall J. 2013. Management of stone disease. Surgery, 31: 354–361.
Merchant ML, Cummins T D, Wilkey D W, Salyer SA, Powell DW, Klein JB, Lederer ED. 2008. Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. Am J Physiol Renal Physiol, 295: 1254–1258.
Miyazawa K, Takahashi Y, Morita N, Moriyama MT, Kosaka T, Nishio M, Yoshimoto T, et al. 2012. Cyclooxygenase 2 and prostaglandin E 2 regulate the attachment of calcium oxalate crystals to renal epithelial cells. Int J Urol, 19: 936–943.
Moe OW. 2006. Kidney stones : pathophysiology and medical management. Lancet, 367:333–44.
Musa D, Dilsiz N, Gumushan H, Ulakoglu G, Bitiren M. 2015. Antitumor activity of an ethanol extract of Nigella sativa seeds Antitumor activity of an ethanol extract of Nigella sativa seeds. Biologia Bratisl, 56: 735–740.
Nouvenne A, Meschi T, Guerra A, Allegri F, Prati B, Borghi L. 2008. Dietary treatment of nephrolithiasis. Clin Cases Miner Bone Metab, 5: 135–141.
Oberg F, Haseeb A, Ahnfelt M, Ponte F. 2009. Herbal melanin activates TLR4 / NF-kB signaling pathway. Phytomedicine, 16: 477–484.
Oncalves RD, Sponchiado PO. 2005. Antioxidant Activity of the Melanin Pigment Extracted from Aspergillus nidulans. Biol Pharm Bull, 28: 1129–1131.
Ragheb A, Attia A, Eldin W S, Elbarbry F, Gazarin S, Shoker A. 2009. The Protective Effect of Thymoquinone, an Anti-oxidant and Anti-inflammatory Agent, against Renal Injury: A Review. Saudi J Kidney Dis Transpl, 20: 741–752.
Romero V, Akpinar H, Assimos DG. 2010. Kidney Stones : A Global Picture of Prevalence , Incidence , and Associated Risk Factors. Rev Urol, 12: 86–96.
Sayed-Ahmed MM, Nagi MN. 2007. Thymoquinone Supplementation Prevents The Development of Gentamicin-induced acute renal toxicity in rats. Clin Exp Pharmacol P, 34: 399–405.
Sayer JA, Moochhalab SH, Thomasb DJ. 2010. The medical management of urolithiasis. Brit J Med Surg Urol, 3: 87–95.
Stone JR, Knutson TL, Kang C. 2010. Bilateral obstructing renal stones: an uncommon cause of acute renal failure. Am J Emerg Med. 28: 5-6
Tozawa K, Yasui T, Okada A, Hirose M, Hamamoto S, Itoh Y, Kohri K. 2008. NF – kB activation in renal tubular epithelial cells by oxalate. Int J Urol, 15: 924–928.
Tsao K, Wu TL, Chang PY, Sun CF, Wu LL, Wu JT. 2007. Multiple Risk Markers for Atherogenesis Associated With Chronic Inflammation Are Detectable in Patients With Renal Stones. J Clin Lab Anal, 21: 426–431.
Ulu R, Dogukan A, Tuzcu M, Gencoglu H, Ulas M, Ilhan N, Muqbil I, et al. 2012. Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury. Food Chem Toxicol, 50: 1675–1679.
Vance S, Benghuzzi H, Wilson-Simpson F, Tucci M. 2008. Thymoquinone supplementation and its effect on kidney tubule epithelial cells in vitro. Biomed Sci Instrum, 44: 477–82.